Ctrl Worx Watch List › Company
ProPhase Labs, Inc. (PRPH): material weakness open 1,033 days
By Russell Tomoum, Ctrl Worx™. Built from its own SEC filings. How the Clock works.
ProPhase Labs, Inc. reported ineffective internal control over financial reporting because of a material weakness in 6 filings since Mar 29, 2024. The latest was its 10-K for the period ended Dec 31, 2025.
Ctrl Worx Watch List™ status
On the ClockStill filing, and no annual report of its own says the weakness is fixed.
Checked against SEC EDGAR: Oct 29, 2026 · Entry #10169
Causes the company named
Financial close and reporting · 9Accounting expertise and resources · 9Revenue recognition · 9Not described · 1Inventory · 1
Material weaknesses in internal controls over financial reporting were identified but their specific causes were not disclosed.
What the latest filing says
Based on this assessment, we determined that the Company’s internal controls over financial reporting were not effective as of December 31, 2025. Remediation Plan We are in the process of continuing to evaluate the material weaknesses and developing a detailed plan for remediation of control deficiencies. We will not consider the material weakness remediated until the remedial controls operate for a sufficient period of time and we have concluded, through testing, that these controls are effectively designed and operating effectively. We will continue to assess the effectiveness of our remediation efforts in connection with our future assessments of the effectiveness of internal control over financial reporting and disclosure controls and procedures throughout 2026. As we continue to evaluate and work to improve our internal control over financial reporting, we may execute additional measures to address potential control deficiencies or modify the remediation plan described above. We will continue to review and make necessary changes to the overall design of our internal control. C [...]
From the controls section of the 10-K filed Jun 1, 2026. Read the full filing on SEC EDGAR.
Company response: ProPhase Labs, Inc. can send a statement or a link to its remediation update to russell@ctrlworx.com. We post it here, unedited and dated.
Filings
| Filed | Form | Period | Controls | Causes | Filing |
|---|---|---|---|---|---|
| Jun 1, 2026 | 10-K | Dec 31, 2025 | Not effective | Not described | EDGAR |
| Apr 1, 2025 | 10-K | Dec 31, 2024 | Not effective | Financial close and reporting; Accounting expertise and resources; Revenue recognition; Inventory | EDGAR |
| Nov 13, 2024 | 10-Q | Sep 30, 2024 | Not effective | Financial close and reporting; Accounting expertise and resources; Revenue recognition | EDGAR |
| Aug 14, 2024 | 10-Q | Jun 30, 2024 | Not effective | Financial close and reporting; Accounting expertise and resources; Revenue recognition | EDGAR |
| May 10, 2024 | 10-Q | Mar 31, 2024 | Not effective | Financial close and reporting; Accounting expertise and resources; Revenue recognition | EDGAR |
| Mar 29, 2024 | 10-K | Dec 31, 2023 | Not effective | Financial close and reporting; Accounting expertise and resources; Revenue recognition | EDGAR |
| Mar 29, 2023 | 10-K | Dec 31, 2022 | Effective | EDGAR | |
| Nov 10, 2022 | 10-Q | Sep 30, 2022 | Not effective | Financial close and reporting; Accounting expertise and resources; Revenue recognition | EDGAR |
| Aug 12, 2022 | 10-Q | Jun 30, 2022 | Not effective | Financial close and reporting; Accounting expertise and resources; Revenue recognition | EDGAR |
| May 13, 2022 | 10-Q | Mar 31, 2022 | Not effective | Financial close and reporting; Accounting expertise and resources; Revenue recognition | EDGAR |
| Mar 31, 2022 | 10-K | Dec 31, 2021 | Not effective | Financial close and reporting; Accounting expertise and resources; Revenue recognition | EDGAR |
Others on the Clock in the same industry
By SEC industry code: 2834, Pharmaceutical Preparations, then related codes.
- Aditxt, Inc. (ADTX) · open since Dec 2023
- CANNAPHARMARX, INC. (CPMD) · open since Dec 2023
- FibroBiologics, Inc. (FBLG) · open since Dec 2023
- NovAccess Global Inc. · open since Dec 2023
- REGENEREX PHARMA, INC. · open since Dec 2023
Follow PRPH for free
Get an email when ProPhase Labs, Inc files a 10-K or 10-Q that reports a material weakness, or says its controls are effective again.
Want the next one the day it's filed?
MW Pro sends an alert the day a company you follow reports a material weakness or says it fixed one. Founding price $990 a year.
Join the MW Pro waitlistLook up any company in Controls Radar™Based on public SEC filings. Causes are grouped into standard categories by Ctrl Worx. The filings are the authority. Ctrl Worx is not affiliated with ProPhase Labs, Inc. or the SEC. Not investment advice. Why you can rely on the Watch List.